Essential thrombocytosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 24: Line 24:


==[[Essential thrombocytosis natural history|Natural History, Complications & Prognosis]]==
==[[Essential thrombocytosis natural history|Natural History, Complications & Prognosis]]==
'''Prognosis'''
* Under strict medical supervision, the life expectancy is usually normal.


==Diagnosis==
==Diagnosis==

Revision as of 19:33, 29 October 2015

For patient information, click here

Essential thrombocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology and Demographics

Risk Factors

Screening

Causes

Differentiating Essential thrombocytosis from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Essential thrombocytosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Essential thrombocytosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Essential thrombocytosis

CDC on Essential thrombocytosis

Essential thrombocytosis in the news

Blogs on Essential thrombocytosis

Directions to Hospitals Treating Essential thrombocytosis

Risk calculators and risk factors for Essential thrombocytosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]

Synonyms and keywords: Essential thrombocythemia, primary thrombocythemia, inherited essential thrombocythemia, inherited Essential thrombocytosis, inherited essential thrombocythemia, inherited ET, congenital essential thrombocytosis, congenital essential thrombocythaemia, congenital essential thrombocythemia, congenital ET, hereditary essential thrombocytosis, hereditary essential thrombocythaemia, hereditary essential thrombocythemia, hereditary ET, familial essential thrombocythemia, familial essential thrombocytosis, familial essential thrombocythaemia, familial ET, Epstein-Goedel syndrome

Overview

Essential thrombocytosis (ET) is a rare hematologic disorder characterized by overproduction of platelets in the absence of an underlying disease.Platelets are responsible for hemostasis that is to control bleeding by forming plugs at the site of injury. Though overproduced, the platelets in ET are usually dysfunctional resulting in the vascular complications.

Historical Perspective

Classification

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes

Differentiating Essential thrombocytosis from other Diseases

Natural History, Complications & Prognosis

Diagnosis

ET is a diagnosis of exclusion. History & Symptoms | Physical Examination | Staging | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Diagnostic criteria

Treatment

Medical Therapy | Special care related to pregnancy | Surgery | Primary Prevention | Secondary Prevention

Resources

Template:Hematology

de:Essentielle Thrombozythämie


Template:WikiDoc Sources